Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Urgency reduced by solifenacin in overactive bladder patients

April 1, 2004

Studies suggest that botulinum A toxin is both effective and safe in bladder disorders

April 1, 2004

Studies reveal tolerability and efficacy of darifenacin in overactive bladder

April 1, 2004

BXL-353 inhibits testosterone-stimulated prostate growth in vivo

March 31, 2004

Stem cell therapy effective in urinary incontinence patients

March 31, 2004

Duloxetine demonstrates efficacy in women with stress urinary incontinence

March 31, 2004

Ranbaxy patents series of novel muscarinic receptor antagonists

March 31, 2004

Positive opinion handed down in Europe for duloxetine for SUI

March 30, 2004

FibroGen research supports HIF activation technology for acute renal failure

March 30, 2004

Novel PDE5 inhibitor for erectile dysfunction by Schering Plough

March 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...